Lifeng Feng

13PUBLICATIONS
5CO-AUTHORS
Molecular targetsInnate immunityElectrometallurgySpeciation and extinctionCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 07, 2026
PIAS4 inhibition induces cell cycle arrest and exhibits a synergistic effect in combination with CDK4/6 inhibitor in breast cancer treatment.

Hui Chen, Xinyang Hu, Lifeng Feng

|Mar 20, 2026
Targeting WIP1 reprograms immunosuppressive tumor microenvironment to potentiate immunotherapy response in colorectal cancer.

Lini Chen, Miaoqin Chen, Shijin Yuan

|Jan 26, 2025
Cuproplasia and cuproptosis, two sides of the coin.

Kaizhong Lu, Chandra Sugiarto Wijaya, Qinghua Yao

|Nov 22, 2024
Erratum for the Clinical and Translational Medicine 'LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability' by Yiran Zhu et al.

Yiran Zhu, Bingluo Zhou, Xinyang Hu

|Jul 21, 2023
RNautophagic regulation of DNMT3a-dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer.

Liyuan Zhu, Yiran Zhu, Fang Li

|Jun 05, 2023
Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.

Weikai Wang, Kaizhong Lu, Xin Jiang

Pageof 3

Frequent Collaborators

3 joint publications

Liyuan Zhu

3 joint publications

Hongchuan Jin

3 joint publications

Yiran Zhu

1 joint publications

Kaizhong Lu